日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.

BCL-xL 作为西妥昔单抗耐药性结直肠癌的治疗靶点。

Asmanidou Stella, Thiel Julia, Ekstrom Thomas L, Schueler Julia, Oswald Eva, Metzger Patrick, Blaumeiser Andreas C, Boerries Melanie, Wiebl Lisa-Marie, Schiffler Ronja, Tamas Raluca, Essmann Frank, Dong Meng, Johnsen Steven A, Kontermann Roland E, Olayioye Monilola A

The making of multispecific immunoglobulins - a clinical perspective

多特异性免疫球蛋白的制备——临床视角

Brinkmann, Ulrich; Kontermann, Roland E

Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR

编码双特异性T细胞衔接器或新型三特异性T细胞衔接器的溶瘤腺病毒,可双重靶向c-MET和EGFR。

Boos, Martin A; Seifert, Oliver; Sawall, Stefanie; Genz, Jessica; Huber, Annika; Hofmann, Ilse; Kontermann, Roland E; Ungerechts, Guy; Nettelbeck, Dirk M

Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3.

靶向 HER2 和 HER3 的三特异性 eFab-eIg T 细胞衔接器

Löffler Ann-Kathrin, Huber Annika, Olayioye Monilola A, Kontermann Roland E, Seifert Oliver

Single intracerebroventricular TNFR2 agonist injection impacts remyelination in the cuprizone model

单次脑室内注射TNFR2激动剂可影响铜嗪模型中的髓鞘再生

Pegoretti, Valentina; Boerema, Ate; Kats, Kim; Dafauce Garcia, Juan M; Fischer, Roman; Kontermann, Roland E; Pfizenmaier, Klaus; Laman, Jon D; Eisel, Ulrich L M; Baron, Wia

Comparison of antibody-scTRAIL Fc fusion proteins with varying valency for EGFR and TRAIL receptors.

比较不同价态的抗体-scTRAIL Fc融合蛋白对EGFR和TRAIL受体的结合情况

Michler Dennis, Seifert Oliver, Pfizenmaier Klaus, Kontermann Roland E

Comparative Assessment of Various Formats of TRAIL in Three-Dimensional Cell Culture and Patient-Derived Tumoroids of Colorectal Cancer

TRAIL技术在三维细胞培养和结直肠癌患者来源类瘤中的不同形式的比较评估

Vafaeinik, Farzaneh; Helmueller, Sarah; Gangi, Alexandra; Ku, Ja-Lok; Kontermann, Roland; Lee, Yong J

The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration.

TNFR1 拮抗剂 Atrosimab 可减少急性神经退行性变小鼠模型中的神经元丢失、胶质细胞活化和记忆缺陷

Ortí-Casañ Natalia, Boerema Ate S, Köpke Karina, Ebskamp Amber, Keijser Jan, Zhang Yuequ, Chen Tingting, Dolga Amalia M, Broersen Kerensa, Fischer Roman, Pfizenmaier Klaus, Kontermann Roland E, Eisel Ulrich L M

Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics

病毒抗体疗法:改造溶瘤病毒以进行多种抗体生物疗法的基因递送

Kontermann, Roland E; Ungerechts, Guy; Nettelbeck, Dirk M

Convergence of pathway analysis and pattern recognition predicts sensitization to latest generation TRAIL therapeutics by IAP antagonism.

通路分析和模式识别的融合预测了IAP拮抗作用对最新一代TRAIL疗法的敏感性

Vetma Vesna, Guttà Cristiano, Peters Nathalie, Praetorius Christian, Hutt Meike, Seifert Oliver, Meier Friedegund, Kontermann Roland, Kulms Dagmar, Rehm Markus